Skip to content

8-KAccepted Sep 16, 8:30 AM ET

La Rosa Holdings Issues Series E Preferred Stock, Raises $200K

LRHCLa Rosa Holdings Corp.

Accepted (ET)

8:30 AM

Sep 16, 2026

Filed

Sep 16, 2026

Documents

12

Size

544.0 KB

Summary

La Rosa Holdings Issues Series E Preferred Stock, Raises $200K

Updated

What Happened

  • La Rosa Holdings Corp. announced it entered into a Securities Purchase Agreement (SPA) with an institutional investor on September 15, 2026 and issued 200 shares of its Series E Convertible Preferred Stock that same day.
  • The shares have a stated value of $1,000 per share (par value $0.0001), producing aggregate gross proceeds of $200,000. The investor also has an option, subject to conditions in the SPA, to purchase additional Series E Preferred Stock at the same stated value in one or more additional closings.
  • The Company previously filed the Certificate of Designation for the Series E Preferred Stock with the Nevada Secretary of State on July 9, 2026 (disclosed in prior 8-Ks filed July 10 and amended July 16, 2026). The SPA is filed as Exhibit 10.1 to this 8-K.

Key Details

  • 200 shares of Series E Convertible Preferred Stock issued on Sept 15, 2026.
  • Stated value: $1,000 per share; par value: $0.0001 per share.
  • Aggregate gross proceeds from the issuance: $200,000.
  • Investor has an option to cause additional closings to buy more Series E shares at $1,000 per share, subject to closing conditions in the SPA.

Why It Matters

  • This transaction provides the company with $200,000 in immediate capital and a potential path for further funding if the investor exercises its option to buy additional preferred shares.
  • Series E preferred stock carries rights and preferences set forth in the Certificate of Designation; those terms (including any conversion, liquidation, or voting features) can affect common shareholders and are described in prior filings and the Certificate of Designation (see the Company’s July 2026 8-Ks and Exhibit 3.1).
  • Investors should review the SPA (Exhibit 10.1) and the Certificate of Designation for full details on rights, potential dilution, and any conditions to additional financings.

AI-written summary · check the filing